Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,205,650
-$802,278 QoQ
Shares Held
3,689,167
+2.4% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 170 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Derivatives in AKBA
reported options exposure · as of Jun 30, 2020CallValue
$165,676
CallShares
12,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. AKBA ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in AKBA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,205,650 | 3,689,167 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,007,928 | 3,602,827 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,577,362 | 4,706,437 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,826,128 | 1,767,813 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,319,767 | 3,934,002 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,230,922 | 2,724,439 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,904,167 | 1,002,194 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $640,554 | 485,269 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $355,895 | 348,918 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,586,984 | 1,413,653 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $88,289 | 71,201 | Shares | Defined | 2024-05-14 | |
| 2023-06-30 | $16,719 | 18,273 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $37,992 | 67,844 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $8,844 | 15,328 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $146,563 | 463,810 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $120,565 | 341,546 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $646,894 | 900,967 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,852,588 | 2,147,163 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,481,062 | 514,258 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $11,777,560 | 3,107,536 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,405,854 | 2,778,687 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,086,053 | 3,602,162 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,644,885 | 1,452,146 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,447,697 | 1,137,533 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $165,676 | 12,200 | Call | Defined | 2020-08-12 | |
| 2020-03-31 | $5,853,669 | 772,252 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||